![Adagrasib Catalog No.:M12926-2 N-dimethylglycyl)amino]-1-[(4-{8-[(1S)-1-hydroxyethyl]imidazo[1](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M13402_1625020690.gif?v=1626918265)
Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
N-dimethylglycyl)amino]-1-[(4-{8-[(1S)-1-hydroxyethyl]imidazo[1
4S)-4-(14-amino-3
Ibrutinib is a Btk inhibitor (IC50: 0
and normalizes tumor-associated vasculature in the Calu-6 non–small cell lung xenograft model
Adagrasib Catalog No.:M12926-2 N-dimethylglycyl)amino]-1-[(4-{8-[(1S)-1-hydroxyethyl]imidazo[1Adagrasib (MRTX849) is a potent, selective, and covalent KRASG12C inhibitor that exhibits favorable drug like properties, selectively modifies mutant cysteine 12 in GDP bound KRASG12C and inhibits KRAS dependent signaling. Product information CAS Number: 2326521 71 3 Molecular Weight: 604. 12 Formula: C32H35ClFN7O2 Synonym: MRTX849 Chemical Name: 2 ((S) 4 (7 (8 chloronaphthalen 1 yl) 2 (((S) 1 methylpyrrolidin 2 yl)methoxy) 5, 6, 7, 8
US$ 13.00
US$ 15.99
US$ 199.50
US$ 20.00
US$ 95.00
US$ 18.95